Brief Intervention for Rural Women at High Risk for HIV/HCV

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Acquired Immune Deficiency Syndrome VirusHepatitis CDrug Abuse
Interventions
OTHER

MI-based HIV Risk Reduction

As the only MI-based intervention identified by the CDC as a best-practice model, the MI-HIV intervention has been shown to demonstrate positive outcomes for criminal justice-involved women randomly assigned to the intervention group for risky sexual activity and drug use with sustained behaviors through 9 months.

Trial Locations (1)

41071

Rural Appalachian Research Center, Hazard

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Michele Staton

OTHER

NCT01840722 - Brief Intervention for Rural Women at High Risk for HIV/HCV | Biotech Hunter | Biotech Hunter